Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients

Felix Keil, MD, Lisa Obenaus, BSc, Victor Rathkolb, MD, Michael Leiner, MD, Robert Spörk, MSc, Elisabeth Koller, MD, Ernst Forjan, MD, Ralph Simanek, MD, Michael Panny, MD, Daniel Lechner, MD, Alexandra Böhm, MD, Anabel Schönmetzler, MD, Theresia Kornberger, MD, Thomas Noesslinger, MD

Blood (2019) 134 (Supplement_1): 5458.

https://doi.org/10.1182/blood-2019-122024

Published: 2019

Journal Articles

Prediction of venous thromboembolism in cancer patients

Cihan Ay, Daniela Dunkler, Christine Marosi, Alexandru-Laurentiu Chiriac, Rainer Vormittag, Ralph Simanek, Peter Quehenberger, Christoph Zielinski, Ingrid Pabinger

Blood (2010) 116 (24): 5377–5382.

https://doi.org/10.1182/blood-2010-02-270116

Published: 2010

Journal Articles

High Soluble P-Selectin and Low Platelet Count as Thrombosis Risk Markers in Glioma Patients.

Rainer Vormittag, Christine Marosi, Prof., Cihan Ay, Ralph Simanek, Ilse Schwarzinger, Matthias Preusser, Katarzyna Elandt, Christoph C Zielinski, Ingrid Pabinger

Blood (2009) 114 (22): 2985.

https://doi.org/10.1182/blood.V114.22.2985.2985

Published: 2009

Journal Articles

Predictive Value of D-Dimer Levels for Venous Thromboembolism in Cancer Patients: Results from the Vienna Cancer and Thrombosis Study (CATS)

Cihan Ay, MD, Rainer Vormittag, MD, Daniela Dunkler, PhD, Ralph Simanek, MD, Alexandru-Laurentiu Chiriac, MD, Johannes Drach, MD, Peter Quehenberger, MD, Oswald Wagner, MD, Christoph Zielinski, MD, Ingrid Pabinger, MD

Blood (2008) 112 (11): 3824.

https://doi.org/10.1182/blood.V112.11.3824.3824

Published: 2008

Journal Articles

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

Cihan Ay, Ralph Simanek, Rainer Vormittag, Daniela Dunkler, Guelay Alguel, Silvia Koder, Gabriela Kornek, Christine Marosi, Oswald Wagner, Christoph Zielinski, Ingrid Pabinger

Blood (2008) 112 (7): 2703–2708.

https://doi.org/10.1182/blood-2008-02-142422

Published: 2008

Journal Articles

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

Cihan Ay, MD, Ralph Simanek, MD, Rainer Vormittag, MD, Daniela Dunkler, PhD, Guelay Alguel, MD, Silvia Koder, Oswald Wagner, MD, Christoph Zielinski, MD, Ingrid Pabinger, MD

Blood (2007) 110 (11): 701.

https://doi.org/10.1182/blood.V110.11.701.701

Published: 2007

Journal Articles

Venous Thromboembolism - A Manifestation of the Metabolic Syndrome?.

Cihan Ay, Theres Tengler, Rainer Vormittag, MD, Ralph Simanek, MD, Wolfgang Dorda, PhD, Thomas Vukovich, MD, Ingrid Pabinger, MD

Blood (2006) 108 (11): 1499.

https://doi.org/10.1182/blood.V108.11.1499.1499

Published: 2006

NARROW

Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients

Prediction of venous thromboembolism in cancer patients

High Soluble P-Selectin and Low Platelet Count as Thrombosis Risk Markers in Glioma Patients.

Predictive Value of D-Dimer Levels for Venous Thromboembolism in Cancer Patients: Results from the Vienna Cancer and Thrombosis Study (CATS)

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

Venous Thromboembolism - A Manifestation of the Metabolic Syndrome?.

Email alerts

ASH Publications

American Society of Hematology

Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients

Prediction of venous thromboembolism in cancer patients

High Soluble P-Selectin and Low Platelet Count as Thrombosis Risk Markers in Glioma Patients.

Predictive Value of D-Dimer Levels for Venous Thromboembolism in Cancer Patients: Results from the Vienna Cancer and Thrombosis Study (CATS)

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

Venous Thromboembolism - A Manifestation of the Metabolic Syndrome?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only